Page last updated: 2024-08-22

4-chlorophenylbiguanide and fluvoxamine

4-chlorophenylbiguanide has been researched along with fluvoxamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brøsen, K; Jeppesen, U; Rasmussen, BB	1

Trials

1 trial(s) available for 4-chlorophenylbiguanide and fluvoxamine

Article	Year
Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanide. Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:3 Topics: Administration, Oral; Adult; Antimetabolites; Aryl Hydrocarbon Hydroxylases; Biguanides; Biotransformation; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluvoxamine; Folic Acid Antagonists; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Proguanil; Selective Serotonin Reuptake Inhibitors; Triazines	1997

Article

Year

Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanide.

Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:3

Topics: Administration, Oral; Adult; Antimetabolites; Aryl Hydrocarbon Hydroxylases; Biguanides; Biotransformation; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluvoxamine; Folic Acid Antagonists; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Proguanil; Selective Serotonin Reuptake Inhibitors; Triazines

1997